Craniofacial malformations are common congenital birth defects and usually caused by abnormal development of the cranial neural crest cells. Some nucleolar ribosome biogenesis factors are implicated in neural crest disorders also known as neurocristopathies. However, the underlying mechanisms linking ribosome biogenesis and neural crest cell (NCC) development remain to be elucidated. Here we report a novel zebrafish model with a CRISPR/Cas9-generated esf1 mutation, which exhibits severe NCC-derived pharyngeal cartilage loss and defects in the eyes, brain, and heart. The expression of several typical NCC markers, including sox10, dlx2a, nrp2b, crestin, vgll2a, and sox9a, was reduced in the head of the esf1 mutants, which indicates that esf1 plays a role in the development of zebrafish NCCs. We demonstrate that, similar to the yeast, loss of esf1 in zebrafish leads to defects in 18S rRNA biogenesis and ribosome biogenesis. We also show strong upregulation of p53 signaling as well as apoptosis, and poor proliferation in mutants. Inactivation of p53 rescues the early tissue defects and pharyngeal cartilage loss observed in esf1 mutants, indicating that increased cell death and pharyngeal cartilage defects observed in esf1 mutants are mediated via upregulated p53 signaling pathways. Based on transplantation analysis, we found esf1 functions in NCC in a cell autonomous fashion. Together, our results suggest that esf1 is required for NCC development and pharyngeal cartilage formation. These studies provide a potential model for investigating the relationship between ribosome biogenesis defects and craniofacial neurocristopathies.
Introduction
Craniofacial malformations are common congenital birth defects that impact the development of the head, face, and neck and account for three-fourths of all human birth defects [1] . Neural crest cells (NCCs) are a Abbreviations AO, acridine orange; CNCC, cranial neural crest cell; DBA, Diamond-Blackfan anemia; dpf, days post fertilization; EMT, epithelial-tomesenchymal transition; ERS, embryo rearing solution; ESF1, 18S rRNA factor 1; gRNA, guided RNA; hpf, hours post fertilization; ISH, in situ hybridization; MO, morpholino; NCC, neural crest cell; pH3, phospho-histone [3H] serine 10; qRT-PCR, quantitative real-time PCR; RP, ribosomal protein; sgRNA, single-guide RNA; TCS, Treacher Collins syndrome; WISH, whole-mount in situ hybridization.
group of multipotent cells specific to vertebrates and it is the aberrant patterning of these cell populations that give rise to congenital craniofacial abnormalities [2] . Cranial neural crest cells (CNCCs) are a subset of NCCs that give rise to nearly all cartilage, bone, and connective tissues found in the head and neck. While CNCCs are initially located at the neural plate border, they undergo epithelial-to-mesenchymal transition (EMT), and migrate along well-defined routes to the various locations of head regions. During and after migration, these cells eventually differentiate into a broad range of derivatives, such as bone, cartilage, dentine, neurons and glia, and pigment cells [3, 4] . Defects in the development of CNCCs and other neural crest disorders are called neurocristopathies and present with severe craniofacial malformations. These defects are a result of impairments in the complex developmental processes that guide induction, migration, proliferation, and differentiation of NCCs. A tightly controlled spatiotemporal signaling network is required for regulating the multistep developmental processes of NCC. A number of signaling pathways have been shown to be necessary for NCC generation, survival, and EMT, including Bmp, Fgf, Wnt, and Shh pathways [5] [6] [7] [8] . These signals working together activate the expression of several transcription factors of highly conserved families, such as Fox, Sox, Pax, and Snail/Slug, and define the NCC territory and control subsequent NCC development [9] [10] [11] . For example, Fgf8 is indispensable for the survival of NCCs that make up the first pharyngeal arch, as shown by the fact that knockdown of Fgf8 results in a lack of craniofacial cartilages due to a failure of NCC migration [12] . Moreover, many studies have shown that mutations in general regulators of housekeeping cellular functions such as transcription or ribosome biogenesis can preferentially cause NCC developmental defects [13] [14] [15] .
Improvements in the molecular understanding of neurocristopathies have revealed a particular connection to ribosome biogenesis defects. Ribosome biogenesis is a fundamental process that provides cells with the molecular machinery to make proteins [16] . In eukaryotic cells, this process starts with the transcription of pre-rRNAs from rDNA by RNA Pol I in the nucleoli [17] . The pre-rRNA are cleaved and processed into 18S, 5.8S, and 28S mature rRNAs. Those rRNAs interact with approximately 80 ribosomal proteins (RPs) to form the small (40S) and large (60S) ribosomal subunits to produce a functional ribosome, which is essential for protein synthesis [18, 19] . This process requires more than 350 assembly factors acting coordinately in time and space and a single mutation in any RP or assembly factor can result in cell type and/or tissue-specific diseases [20] .
For example, Treacher Collins syndrome (TCS) and Diamond-Blackfan anemia (DBA) are the most prevalent and best-understood neurocristopathies that present with craniofacial hypoplasia with the underlying causes involving aberrant ribosome biogenesis [15] . In a mouse model of TCS, a mutation in Tcof1, a nucleolar phosphoprotein, results in reduced numbers of NCC, while mutations in zebrafish Wdr43, a ribosome biogenesis factor, result in defects restricted to NCCderived craniofacial cartilages [13, 21] . Recent findings indicate that defects in ribosome biogenesis are linked to the p53 apoptosis pathway. Various studies have demonstrated that mutations in nucleolar proteins involved in rRNA synthesis or ribosomal subunit assembly affect ribosome biogenesis and activate a p53 response through a nucleolus-mediated stress [22] [23] [24] [25] . Interestingly, inhibition of p53 function can rescue craniofacial abnormalities in mouse Tcof1 mutants, without rescuing ribosome biogenesis defects [26] .
18S rRNA factor 1 (ESF1), an essential nucleolar protein that is highly conserved from yeast to humans plays a direct role in early pre-rRNA processing and basal transcription [27, 28] . It was named by Hughes and his colleagues for its direct role in 18S rRNA biogenesis [27] . Although ESF1 is an essential nucleolar protein in terms of ribosome biogenesis, the function of ESF1 in proper embryonic development is unknown.
In the present study, we develop a novel CRISPR/ Cas9-generated zebrafish with mutations in the esf1 gene. Our results show that mutant fish exhibited severe pharyngeal cartilage loss due to deficits in NCC development. We also found that mutation of esf1 resulted in reduced production of 18S rRNA, consistent with the 18S rRNA biogenesis defects observed in yeast. In addition, the esf1 mutant early tissue defects and pharyngeal cartilage loss could be partly rescued by a knockdown of p53 signaling, which implies that the phenotype observed in esf1 mutants was partially mediated via upregulated p53 signaling pathways. Using cell transplantation studies, we demonstrate that esf1 acts cell autonomously in the NCC development. Together, our findings provide new insight into roles for esf1 in development and NCC-derived craniofacial cartilages. Our esf1 mutant is a potential in vivo model to mimic human craniofacial neurocristopathies.
Results
Zebrafish esf1 is expressed in a tissue-specific pattern
To examine the potential role of esf1 in embryonic development, we first investigated its spatiotemporal expression pattern by RT-PCR and whole-mount in situ hybridization (WISH) during zebrafish embryonic development. RT-PCR results showed that zebrafish esf1 was maternally deposited and expressed at all embryonic stages from one-cell to 120 h post fertilization (hpf) (Fig. 1A) . WISH with a zebrafish esf1 antisense probe indicated the ubiquitous presence of esf1 transcripts at different developmental stages. The esf1 transcript was expressed in a ubiquitous manner from the one-cell stage to 12 hpf; however, the optic primordium and prospective brain were stained more deeply (Fig. 1B-I) . From 18 to 24 hpf, the esf1 expression becomes restricted to midbrain, eye, and pharyngeal primordia (Fig. 1G-Q) . At 30, 48, and 72 hpf, strong esf1 mRNA signal was observed in pharyngeal arch tissues, retina, liver, and pectoral fin buds (Fig. 1P-V) . High expression was observed in the liver from 96 to120 hpf, and strong expression in the gut was also seen at 120 hpf ( Fig. 1W-Y) .
To better examine the expression of esf1, we performed sectioned in situ hybridization (ISH) and demonstrated that esf1 mRNA is expressed in pharyngeal arches and neurepithelium at 72 hpf (Fig. 1Z ). This tissue-specific expression pattern of esf1 implies that zebrafish Esf1 may play an important role in the craniofacial structure formation during embryonic development.
Knockout esf1 gene via the RNA-guided Cas9 nuclease
To investigate the role of Esf1 in embryonic development, we decided to knockout esf1 via the CRISPR/ Cas9 system. Firstly, we analyzed Esf1 protein domains and found a putative NLS and a high conserved NUC153 domain in its C terminus ( Fig. 2A) . In order to knockout the two conserved domains and all isoforms, the target site was selected in the sixth exon (Fig. 2B) . Next, to examine the subcelluar localization of N terminus and C terminus that based the location of the target, we generated C-terminal EGFPtagged zebrafish Esf1 full-length, N terminus (residues 1-349) and C terminus (residues 405-759) constructs (Fig. 2C) , which we transfected into cultured Hela cells. The EGFP-tagged full-length and C terminus Esf1 protein showed perfect overlapping expression pattern with mCherry-tagged B23, a nucleolar marker protein, while EGFP-tagged Esf1 N terminus lost its exclusive nucleolar localization (Fig. 2D) . These results indicate that loss of the C terminus affected Esf1 protein subcellular localization, and predicted the esf1 mutant generated by this target may have important phenotype.
To obtain zebrafish esf1 mutant, we synthesized Cas9 mRNA and guided RNA (gRNA) in vitro (Fig. 3A,B (Fig. 3C) , and extracting genomic DNA of embryos collected at 48 hpf for PCR amplification of regions spanning the target site, we acquired a 29% mutation efficiency in F0 embryos via digestion with MwoI (Fig. 3D) . Then, we acquired heritable mutant F 0 fish via digestion with MwoI (Fig. 3E) . By screening and sequencing the carriers (F 1 ) adults, we obtained three mutated alleles named esf1 ouc3 , esf1 ouc4 , esf1 ouc5 , respectively (Fig. 3F ). All these three alleles lead to frameshift mutations, and introduced premature stop codons, respectively (Fig. 3F,G) . These mutated alleles are predicted to encode a truncated Esf1 protein, and will help to understand the roles of esf1 gene in zebrafish.
Phenotype of the esf1 mutants
Next, developmental analyses showed that esf1 mutants are first distinguishable at 18 hpf by a distinct area of necrotic cells present in the presumptive eye region, compared to wild-type (Fig. 4A ,Aʹ, oval). At 24 hpf, a larger area of necrosis was detected primarily in neural and pharyngeal tissues (Fig. 4B ,Bʹ, oval), while at 30 hpf, esf1 mutants present a phenotype showing a distinct hydrocephaly in hindbrain ventricles (Fig. 4C ,Cʹ, arrow) and a thinned midbrain-hindbrain boundary (MHB) (Fig. 4Cʹ, arrowhead) . From 48 to 96 hpf, a variety of phenotypes were found, as follows: coloboma of the eye with microphthalmia (Fig. 4Dʹ , arrow), severe craniofacial jaw malformations and microcephaly (Fig. 4Eʹ, bracket) , unshaped intestinal bulb (Fig. 4Fʹ, arrowhead) , and heart malformations with an edema of pericardial cavity (Fig. 4Fʹ, arrow) . Compared with the wild-type embryos, the swim bladder of homozygous is either absent or uninflated (Fig. 4Fʹ, asterisk) . Eventually, the homozygous recessive esf1 mutants die at about 6 dpf, and those phenotypes are applicable to all three alleles (Fig. 4Gʹ-G‴) . To detect cartilage defects in esf1 mutant, alcian blue staining was performed at 120 hpf. The staining showed that almost all pharyngeal cartilages and most of the dorsal neurocranium were missing in esf1 mutants, except the deformed trabeculae ( Fig. 4H-Iʹ) . These data show that the phenotype observed in esf1 mutants is consistent with the expression pattern of esf1. We also found that one quarter of the offspring of the carriers (F 1 ) presented severely morphological abnormalities, which was in accordance with Mendelian principles. The abnormal offspring were homozygous, indicating that the mutation was recessive ( Fig. 4J) . We next performed rescues by injecting full-length wild-type esf1 mRNAs into one-cell stage esf1 mutants embryos. Analyses of injected embryos at 24 hpf revealed injection of esf1 mRNA could efficiently rescued the early microphthalmia, hydrocephaly in hindbrain ventricle, and neural tissue necrosis (59% of esf1 À/À embryos were rescued) ( Fig. 5A-C) . At 5 dpf, the mutants larvae injected esf1 mRNA developed a larger jaw than the GFP-injected mutants larvae, and their head was more normal (Fig. 5D -G). Alcian blue staining visually revealed injection of esf1 mRNA was able to restore the mutants' pharyngeal arch cartilage formation (42% of esf1 À/À larvae were rescued), although the normal patterning of pharyngeal cartilage structures was not rescued (Fig. 5H-K) . Taken together, these data provide strong evidence that the abnormal expression and function of esf1 results in an esf1 mutant-specific phenotype and reveals that esf1 is essential for craniofacial cartilage development in zebrafish.
Abnormal development of the esf1 mutant is caused by cranial neural crest defect
In the embryogenesis of zebrafish, the majority of the craniofacial cartilage is derived from cranial NCCs [29, 30] . The occurrence of defective pharyngeal arch cartilages in the esf1 mutant embryos strongly suggests that the cranial NCCs are affected by the esf1 mutation. To test this hypothesis, we set out to examine the developmental expression of several NCC markers. We found that the NCC specification markers foxd3, sox9a, pax3a, and tfap2a [31] [32] [33] [34] [35] did not differ between esf1 mutants and wild-type embryos at 12 hpf, indicating that neural crest induction was unaffected
. Since normal migration of cranial NCCs plays an essential role in the proper development of pharyngeal arches, we explored the effect of esf1 mutation on markers of NCCs migratory patterns, including: sox10, transcription factor implicated in neural crest migration and differentiation [36] ; the pan-neural crest marker crestin, expressed in premigratory and then in actively migrating NCCs [37] ; nrp2b, expressed in the pharyngeal primodium derived from the migrating cranial NCCs [38] ; and dlx2a, which is expressed in the migrating cranial NCCs that contributes to the pharyngeal arches [39] . We found that the expressions of sox10, crestin, nrp2b, and dlx2a were greatly reduced in the esf1 mutants as compared with age-matched wild-type sibling embryos (Fig. 6E-N  0 ). In addition, the expression areas of vgll2a and sox9a, which are required for morphogenetic processes and differentiation of pharyngeal arch cartilages [29, 30, 40] , were also reduced in esf1 mutants ( Fig. 6O-P 0 ), demonstrating again that the pharyngeal arch cartilages were affected in the esf1 mutants. To better observe and study the NCC defects in esf1 mutants, we generated a Tg(fli1a: EGFP)/esf1 mutant line, which expresses EGFP in cranial neural crest derivatives as well as in blood vessels [41, 42] . We observed that esf1 mutant embryos exhibited less GFP signals, and abnormal NCC migration and pharyngeal arch formation, as compared to age-matched wild-type siblings (Fig. 6Q,Q 0 ). To refine the time window of esf1 involved in NCC development, we used NCC marker sox10 to identify which steps in NCC developmental was affected in more detail. The WISH analyses of sox10 revealed that esf1 mutants exhibited reduced sox10 expression at 18 hpf, suggesting that the step of neural crest early migration was affected (Fig. 7) .
esf1 mutants exhibit 18S rRNA biogenesis and ribosome biogenesis defects Previously, it has been shown that Esf1p (Ydr365cp), as an evolutionarily conserved nucleolar protein, is required for in pre-rRNA processing and 18S rRNA biogenesis in yeast [27] . First, we investigated the biogenesis of 18S rRNA in zebrafish esf1 mutant embryos. Agarose gel electrophoresis of total RNA isolated from the esf1 mutant and wild-type sibling embryos at 48 hpf revealed a reduction in the 18S rRNA in esf1 mutants resulting in an elevated 28S/18S ratio compared to that of wild-type siblings (Fig. 8A-B) . Previous studies of ESF1 in yeast revealed ESF1 is required for pre-rRNA processing at cleavage sites A 0 , A 1 , and A 2 that lead to production of the mature 18S rRNA [27] . By means of RT-PCR and qRT-PCR, we revealed rRNA precursor (5 0 -ETS-A 1 -18S) in the esf1 mutants was much more abundant than the wild-type ( Fig. 8C-E) . This indicates that mutation of esf1 may preclude processing at site A 1 in zebrafish.
Secondly, to investigate the impact of esf1 mutation on ribosome biogenesis, we prepared extracts of wild-type and esf1 mutants larvae at 72 hpf and fractionated the ribosomal subunits on sucrose density gradients. We observed that the peaks of 40S subunits and 80S monosomes in esf1 mutants are more strongly decreased compared to that in wild-type; however, no difference was observed in 60S subunits (Fig. 8F-G) . This result indicates esf1 mutation primarily impacting on the production of 40S subunits. Together, these results are consistent with previously published results showing that depletion of yeast Esf1p resulted in a striking loss of 18S rRNA [27] , and indicates a conserved function for vertebrate ESF1 and yeast Esf1p exists for ribosome biogenesis.
esf1 mutant exhibits increased apoptosis and p53 signaling
Recently, ribosome biogenesis defects have been described to be associated with the activation of p53 signaling pathway, cellular apoptosis, and reduced proliferation [43] [44] [45] [46] . Based on the tissue necrosis and NCC development defects observed in esf1 mutants, thereby we examined cell death and cell proliferation in developing esf1 mutant and wild-type embryos. Analyses of acridine orange (AO)-stained embryos clearly demonstrated significantly upregulated apoptosis in the cranial region of the esf1 mutants (Fig. 9A,  B) . Meanwhile, phospho-histone H3 (pH3) IF analyses revealed cell proliferation was decreased in esf1 mutants as compared to age-matched wild-type siblings (Fig. 9C,D) . Moreover, the esf1 mutants display high levels of p53 (Fig. 9E,F) and its target genes, including dN113p53, mdm2, cyclinG1, and p21 compared to wild-type sibling embryos (Fig. 9G-J) . Since the upregulation of p53 expression is well known to induce cell death, we next tested whether p53 inactivation could rescue the esf1 mutant phenotype. We found that the early tissue defects and pharyngeal cartilage formation of esf1 mutant was rescued in p53 morpholino (MO)-injected esf1 mutants (Fig. 9K ,L and M,P), which is similar to the previous reports in the Treacher Collins mouse model [26] . This result implies that increased cell death and cartilage defects observed in esf1 mutants are partially mediated via upregulated p53 signaling pathway.
esf1 acted in NCC through a cell autonomous mode
The WISH showed esf1 is expressed in neural tissue and in other cranial ectodermal derivatives. Moreover, the esf1 mutant embryos present distinct necrotic tissue, overt hydrocephaly in brain ventricles, and dysmorphic forebrain and midbrain. Thus, the neural crest developmental defects in esf1 mutants might be caused indirectly by the surrounding necrotic tissues or abnormal environment signals. To address whether esf1 acted in NCCs through a cell autonomous mode, we employed a cell transplantation approach. In normal zebrafish embryos, from 12 to 36 hpf, the transcription factor sox10 expresses in premigratory NCC, migrating NCC, NCC in pharyngeal arches, pharyngeal arches cartilage progenitors derived from NCC, and otic epithelium, in turn, and is required for NCC migration, survival, multipotency maintenance, and differentiation [47, 48] (Figs 6E-F 0 and 7). First, we transplanted cells from 4 hpf WT donor injected with biotinylated-dextran into WT host. At 36 hpf, we processed the host embryos to reveal sox10 expression in blue and biotin in brown. Double-labeled donorderived cells were readily distinguished from hostderived cells expressing sox10 singly (Fig. 10A,E,E 0 ). Next, we performed similar transplant experiments from WT donor into esf1 À/À mutant host. In esf1 À/À mutant hosts, which show a severe reduction in sox10 expression, and the double-labeled donor-derived cells were also normally found in pharyngeal arches region (Fig. 10B,F,F  0 ) . We also conducted the same transplant in reverse, using esf1 À/À donor and WT host. In such chimeras, esf1 À/À donor-derived cells were not found in the cranial sox10-labeled pharyngeal arches primordial cells (Fig. 10C ,G,G 0 ). Together, these cell transplant studies support a cell autonomous requirement for esf1 in neural crest migration, survival, and differentiation. Error bars represent mean AE SEM; **P < 0.01; ***P < 0.001; ns, no significant difference. ) pharyngeal arch cartilage formation. Numbers of injected embryos scored are indicated at the top of each bar. Error bars represent mean AE SEM; *P < 0.05; **P < 0.01; ***P < 0.001.
Discussion
In this study, we show that the mutation of esf1 lead to defects in NCC development and NCC-derived pharyngeal cartilage formation in zebrafish. In our esf1 mutants, WISH using NCC markers revealed clear reductions in the migratory NCC-expressed domains, as compared to age-matched wild-type siblings. Furthermore, we also observed aberrant pharyngeal arch development in the Tg(fli1:EGFP)/esf1 mutant line, which is used to trace the derivatives of the NCC. We found that esf1 mutants exhibited reductions in GFP signals and defects in NCC migration and pharyngeal arch formation. Taken together, our results indicate that pharyngeal cartilage defects in esf1 mutants are mainly caused by cell death in NCCs. WISH analyses revealed esf1 is expressed in cranial neural tissue. Moreover, the esf1 mutant embryos showed distinct necrotic tissue. Thus, the neural crest developmental defects in esf1 mutants might be caused indirectly by defects in surrounding neural tissues. However, our transplant studies support a cell autonomous requirement for esf1 during neural crest migration, survival, and differentiation. We believe that our findings have added to the knowledge of the esf1 in development. More importantly, through detailed analyses of the esf1 mutants, we revealed the concept that neural crest is one of the primary and vulnerable tissues to be affected in response to nucleolar protein mutations, which is consistent with the fact that human neurocristopathies usually result from housekeeping gene mutations. Our future work will focus on refining the new biochemical insights on how nucleolar stress response was triggered in NCCs as well as in congenital diseases by the identification of esf1-related factors. Eukaryotic ribosome biogenesis is a vital and remarkably complex process that is essential for protein translation and cell growth. It requires the accurate processing of pre-rRNAs into mature rRNAs (28S, 18S, 5.8S, and 5S) and the complex assembly of approximately 80 core RPs [49] . A previous study has reported that Esf1p in yeast is essential for viability [50] , and our homozygous esf1 mutants died at about 6 dpf demonstrating that esf1 encodes a protein indispensable for life. In yeast, Esf1p has been shown to be an essential nucleolar protein for 18S rRNA biogenesis and depletion of Esf1p resulted in a striking loss of 18S rRNA [50] . Here we show that mutation of zebrafish esf1 also results in reduced level of 18S rRNA and ribosome biogenesis defects. Thus, the roles of esf1 in the 18S rRNA biogenesis and ribosome biogenesis are evolutionally conserved among different species.
Recent studies have already shown that mutations in RPs or ribosome biogenesis factors cause a group of tissue-specific human diseases, collectively called ribosomopathies [21] . Interestingly, recently improved molecular understanding of some neurocristopathies revealed a particular connection to ribosome biogenesis defects, which appear to particularly affect aspects of NCCs. For example, mutations in several nucleolar proteins (such as TCOF1, POLR1C, and POLR1C) are associated with human congenital craniofacial hypoplastic TCS. Mutation of those genes lead to ribosome biogenesis defects, which in turn increase P53 protein levels and can lead to apoptosis of NCCs and hypoplastic structures of the craniofacial skeleton [15, 51] .
Here we present data showing that mutation of esf1 results in a variety of developmental defects, including brain, eye, heart, swim bladder, and craniofacial structures. Although esf1 mutants displayed several organs and tissues defects, the phenotype observed here appeared mainly restricted to NCC derivatives such as pharyngeal arch cartilages. This phenotype raises the question of how a mutation in esf1 can lead to a specific craniofacial phenotype. One reason could be that the zebrafish esf1 is mainly expressed in and required for the development of the cranial neural crest and pharyngeal arch region. Another possibility is that there is a specific sensitivity of the neural crest to altered ribosome biogenesis. Cells with defects in 18S rRNA biogenesis or ribosome biosynthesis cannot effectively produce new ribosomes thereby limiting their capacity to produce new proteins necessary for protein synthesis. It is conceivable that the specific processes of EMT and long-range migration inherent to NCCs, impose a particular burden on these cells to command a well-functioning biosynthetic machinery and thus a particular sensitivity to defects in ribosome biosynthesis [15] . And as such, the pharyngeal cartilage formation is particularly affected by defects in ribosome biosynthesis due to a specific sensitivity imposed by their progenitors.
Previous studies have shown that defects in ribosome biogenesis can activate p53 pathway and nucleolar stress-induced apoptosis and cell cycle arrest [46] . Mutations in the RP gene RPS19 is associated with one well-characterized ribosomopathy, DBA. It had been shown that p53 plays a role in mediating the DBA phenotype [52] [53] [54] . Similarly, mutation in the tcof1 gene is most commonly associated with TCS. In the mouse model, mutations in tcof1 disrupt ribosome biogenesis and are characterized by a stimulation of the nucleolar stress response. This activates the p53 apoptosis pathway and results in a deficiency in migrating NCCs and subsequent severe craniofacial malformations [51] . Here we observe a similar event in that apoptosis was significantly upregulated in esf1 mutants. Additionally, inactivation of p53 rescued the early defects of esf1 mutants, suggesting that increased cell death and the defects observed in esf1 mutants were mediated in part by upregulated p53 signaling pathway.
Together, our data reveal a novel role of the ribosome biogenesis factor esf1 during embryonic development of zebrafish. Mutation of esf1 results in defects in pharyngeal cartilage formation due to impaired cranial NCC development. Transplants suggest that esf1 functions cell autonomously in neural crest development. Therefore, we introduce the esf1 mutant as a potential model for further investigations in human congential diseases due to cranial NCC defects.
Materials and methods

Experimental animals
Tubingen esf1 mutant and wild-type zebrafish (Danio rerio) were raised at 28.5°C and kept under standard aquaculture conditions. Embryos obtained by natural cross were cultured in embryo rearing solution (ERS) at 28.5°C and staged according to standard methods [55] . For WISH analyses, pigment formation was inhibited by treating embryos with 1-phenyl-2-thiourea (PTU; Sigma-Aldrich, St. Louis, MO, USA) [0.003% (w/v)] as previously described (The Zebrafish Book, U. Oregon Press). Different developmental stages were determined as described [55] . All experimental procedures on zebrafish embryos and larvae were approved by and conducted in accordance with the Ethical Committee of Experimental Animal Care at Ocean University of China.
RNA extraction and RT-PCR analysis
Total RNA was extracted from embryos using TRIzol Ò reagent (Invitrogen Life Technologies, Carlsbad, CA, USA). The cDNAs were synthesized using M-MLV (Promega, Madison, WI, USA) with Oligo(dT) 18 as primer. RT-PCR was performed using premix Taq DNA polymerase (Takara, Dalian, Liaoning, China) with the following primers: esf1-RT-forward (5 0 -CAGAAAACCCT
Whole-mount in situ hybridization
Whole-mount in situ hybridization was performed as described previously [56] . Embryos were fixed overnight in paraformaldehyde [4% (w/v)] in PBS at 4°C. After washing, embryos were stored in methanol at À20°C until use. The plasmid containing the zebrafish esf1 partial ORF and 5 0 -UTR was used to generate sense and antisense RNA riboprobes using DIG RNA labeling mix (Roche, Basel, Switzerland) following standard procedures. The information for all probes was listed in Table S1 .
Plasmid construction and subcellular localization
These plasmids (pCS2-Esf1-FL-eGFP, pCS2-Esf1-N-eGFP, pCS2-Esf1-C-eGFP) were constructed by PCR using the following primers: Esf1-FL/N-forward (5 0 -CCGGATCCCG
All PCR products were amplified by RT-PCR using KOD plus DNA polymerase (TOYOBO, Shanghai, China) and cloned into the pCS2 + enhanced green fluorescent protein (pCS2-eGFP) expression vector. All of the plasmids were confirmed by sequencing. These constructs were then cotransfected with pCS2-B23-mCherry into HeLa cells using polyethylenimine (Polysciences, Inc., Warrington, PA, USA) . After 24 h of growth at 37°C, transfected cells were fixed with 4% PFA for 15 min at room temperature, washed with PBS for 2 9 5 min, and permeabilized with 0.25% TritonX-100 in PBS for 5 min. Then following wash with PBS for 2 9 5 min, the cells were stained with DAPI (1 : 3000 in PBS) for 15 min. The stained cells were imaged using a Leica DMI6000B invert microscope (Leica Microsystems GmbH, Wetzlar, Germany).
Preparation of Cas9 mRNA and esf1 sgRNA
The zebrafish esf1 mutants we generated using the CRISPR/Cas9 system. The system is a two-component system formed by a dual NLS-tagged Cas9 protein and a single-guide RNA (sgRNA). Both components are first generated as RNAs by in vitro transcription. For making humanized Cas9 mRNA, the human codon-optimized cas9 plasmid pSP6-2sNLS-spCas9 was used as transcription template. The plasmid were linearized by XbaI digestion and purified by phenol/chloroform extracting. The capped hCas9 mRNA was synthesized using mMESSAGE mMA-CHINE Kit (Ambion, Austin, TX, USA) according to the manufacturer's instruction. For making sgRNA, the transcription template DNA was amplified from the plasmid pT7-gRNA, a plasmid containing the T7 promoter and the crRNA: tracrRNA sequences. The following two primers were used for PCR amplified: forward primer (T7 + 20 bp target sequence + 23 bp gRNA scaffold, 5 0 -GAAATTA ATACG-ACTCACTATAGGAGTGTGACTCTGCTGAA AGTTTTAGAGCTAGAAAT-3 0 ); reverse primer (25 bp gRNA scaffold, 5 0 -AAAAAAAGCACCGACTCGGTGC CAC-3 0 ). The quality of the PCR product was checked on a 1.5% agarose gel. Approximately 1.5 lg of PCR product was used as template to transcribe sgRNA by in vitro transcription using T7 RNA polymerase (Promega). Then sgRNA was digested by DNase I for 30 min at 37°C, and precipitated using LiCl overnight at À20°C.
Microinjection
To obtain injected F 0 embryos, the wild-type embryos were collected and microinjected with 1 nl of Cas9 mRNA (375 ngÁlL À1 ) and esf1 sgRNA (20 ngÁlL À1 ) at one-cell stage embryos. After injection, the embryos were raised in ERS and maintained at 28.5°C. Embryos were grown to 2 dpf and genomic DNA was extracted from 15 embryos used for mutation detection. For the rescue experiment, the capped esf1 mRNA was generated in vitro from linearized pCS2-Esf1-FL-eGFP using SP6 polymerase in the mMES-SAGE mMACHINE Kit (Ambion). The synthesized mRNAs was diluted with phenol red dye to 10 ngÁlL
À1
, and approximately 1 nL were microinjected into one-cell stage esf1 mutants embryos. The p53 MO was purchased from Gene Tools, LLC, and its sequence as followed: p53 MO (5 0 -GCGCCATTGCTTTGCAAGAATTG-3 0 ) [57] . To knockdown p53 translation, 4 ng per embryo p53 MO was injected into one-cell stage embryos.
Alcian blue staining
Zebrafish embryos were anesthetized by 0.08% Tricane (Sigma-Aldrich) and fixed overnight in 4% paraformaldehyde with PBS at 4°C. After fixation, the fixed embryos were washed in PBS for 10 min, and were transferred into a 0.1% solution of Alcian blue (Sigma) dissolved in ethanolacetic acid (80% ethanol, 20% acetic acid). The stained embryos were rehydrated through ethanol series (90%, 50%, 30% in water), and digested overnight in 50 mg/ml trypsin in 30% sodium tetraborate. Then they were destained by a glycerine series (20%, 50%, and 80%) and stored in glycerol.
Western blot
Embryos were completely deyolked in ERS and washed with PBS. The embryos were collected by centrifugation and lysed with RIPA buffer containing 150 mM NaCl, 50 mM Tris, 0.5% NP-40, 1 mM EDTA, 0.1% SDS, PH 7.5, with protease inhibitors (Roche) at 4°C for 30 min followed by centrifugation to remove the debris. Protein samples were heated to 95°C for 5 min with 59 Protein Loading Dye. After separation in a 12% SDS/PAGE, the proteins were transferred to PVDF membranes. The primary antibodies were as follows: anti-p53 human (sc-53394) and anti-Actin (sc-1615) (Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA).
Real-time qRT-PCR and RT-PCR
Total RNA was extracted from 30 wild-type and 30 esf1 mutants embryos at 24 hpf using Trizol Reagent (Invitrogen). Total RNA (1.5 lg) was reverse transcribed into cDNA by PrimeScript TM RT reagent Kit (Takara) according to the manufacturer's protocol. Gene expression was quantified by qRT-PCR using SYBR Premix Ex Taq TM II (Takara). The primer sequences of zebrafish full-length p53 and its target genes dN113p53, mdm2, cyclinG1, and p21 were used as described [58, 59] . To calculate the expression level of target genes, results were normalized to bactin. For RT-PCR analysis of pre-rRNA processing intermediates (5 0 ETS-A1-18S), the total RNA samples were reverse transcribed into cDNAs by using the Random 6 mers of PrimeScript TM RT reagent Kit (Takara) and subjected to RT-PCR/qRT-PCR analysis; results were normalized to 28S rRNA. The primers were used for amplification as follows 
Cell death and proliferation assays
For cell death assay, live embryos were incubated for 30 min in 2 lgÁmL À1 AO (Sigma-Aldrich) stain at 28.5°C.
Embryos were washed in distilled water three times, and anesthetized by 0.08% Tricane. For Cell proliferation, phosphorylated histone H3 (serine 10) (Cell Signaling, Danvers, MA, USA) was recognized by a rabbit monoclonal antibody, and detected with the anti-rabbit goat antibody conjugated with Alexa fluor 594 (Life Technologies, Grand Island, CA, USA). The stained embryos were imaged using a Leica DMI6000B invert microscope. Quantifications were performed by averaging the results of counting the number of labeled cells in the hindbrain region (cell death, WT or esf1 À/À embryos, n = 30; cell proliferation, WT or esf1 À/À embryos, n = 20). For manual counting of apoptotic cells, embryos were embedded in 2% methyl cellulose and then imaged using identical exposure parameters at a magnification of 9100. In the captured images, each bright fluorescent spot correspond to an apoptotic cell signal. All AO-labeled cells in hindbrain region in focus were counted.
Polysome fractionation
Polysomes were prepared and fractionated on 10-45% sucrose gradients as described [59] . Fifty wild-type and 50 esf1 mutants larvae at 72 hpf were lysed in cold lysis buffer containing 50 mM Tris/HCl pH 7.4, 2.5 mM MgCL 2 , 150 mM KCl, 1% Triton X-100, 3 mM DTT, 0.5% sodium deoxycholate, plus Complete Protease Inhibitor Cocktail (Roche) and 120 UÁmL À1 RNase inhibitor (Roche), and incubated on ice for 30 min. The nuclei and cellular debris were removed by centrifugation (15 800 g, 20 min at 4°C).
The cytoplasmic extracts were quantitated by an Enhanced BCA Protein Assay Kit (Beyotime Biotechnology, Shanghai, China). Equal amounts of extracts were loaded onto a linear low salt (80 mM NaCl) 10-45% sucrose gradient (10 mL) and ultracentrifuged for 3 h at 250 000 g at 4°C. Sucrose gradients were fractionated, and absorbance at 254 nm was monitored using an UV detector (Ultrospec 2100 pro, Biochrom Ltd., Cambridge, UK). Data were digitized using Excel software and GRAPHPAD PRISM (GraphPad Inc., San Diego, CA, USA).
Cell transplantation
Transplantation experiments were carried out as previously described [60] . The donor embryos were injected at the one-cell stage with 5 nL of 1% lysine-fixable biotinylateddextran, 10 000 MW (Sigma). At sphere stage (4 hpf), about 30 cells were withdrawn from the donor embryo with a manual-drive syringe fitted with an oil-filled needle and inserted into the host embryo at the same stage. The host and donor embryos were kept in 96-cell plate and allowed to develop to 36 hpf, when embryos genotyping was carried out. Subsequently, the host embryos were fixed and processed to reveal the expression of NCC marker gene sox10 by whole-mount ISH, and to reveal biotin with an SABC kit (BOSTER Biological Technology Co. Ltd, Pleasanton, CA, USA) and DAB kit (BOSTER Biological Technology Co. Ltd) according to the manufacturer's protocol.
Statistical analysis
All data were analyzed with GRAPHPAD and the P values were calculated with Student's t-test, shown as mean AE SEM. P values < 0.05 were regarded as statistically significant.
